Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
First-in-human trial naar oraal vectorvaccin tegen hiv-1
dec 2018 | HIV, Vaccinatie, Virale infecties